Evidence map›Paper›PMID 26838724›Full record

ArticlemBio2016

A Novel Secreted Protein, MYR1, Is Central to Toxoplasma's Manipulation of Host Cells.

Magdalena Franco, Michael W Panas, Nicole D Marino, Mei-Chong Wendy Lee, Kerry R Buchholz, Felice D Kelly, Jeffrey J Bednarski, Barry P Sleckman, Nader Pourmand, John C Boothroyd

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 184 citations in OpenAlex.

  1. Article
  2. A Suite of EightbioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. mBio · 2026
    Article
  5. Dense granule proteins: key mediators ofFrontiers in medicine · 2026
    Review
  6. Reconsidering themBio · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Magdalena FrancoDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Michael W PanasDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Nicole D MarinoDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Mei-Chong Wendy LeeDepartment of Biomolecular Engineering, University of California, Santa Cruz, California, USA.
Kerry R BuchholzDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Felice D KellyDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Jeffrey J BednarskiDepartment of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, USA.
Barry P SleckmanDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri, USA.
Nader PourmandDepartment of Biomolecular Engineering, University of California, Santa Cruz, California, USA.
John C BoothroydDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA jboothr@stanford.edu.
Stanford University · USUniversity of California, Santa Cruz · USWashington University in St. Louis · USLawrence Livermore National Laboratory · US

Funding

WHOLE YEAST GENOME TRANSCRIPTIONAL AND FUNCTIONAL GENE MAPS--A FEASIBILITY STUDYP01HG000205 · NHGRI · STANFORD UNIVERSITY · PI HOWE, ROGER THOMAS, JI, HANLEE P · 1990 to 2016
$120.9M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
MOLECULAR BASIS OF HOST-PARASITE INTERACTIONT32AI007328 · NIAID · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 1987 to 2026
$11.9M
VECTOR COREP30NS069375 · NINDS · STANFORD UNIVERSITY · PI STEINBERG, GARY K · 2011 to 2019
$6.3M
ATM FUNCTION DURING V(D)J RECOMBINATIONR01AI074953 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2009 to 2023
$5.9M
Strain-specific Host-Pathogen Interactions in ToxoplasmosisR01AI073756 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 2007 to 2016
$4.2M
INTEGRATION OF DNA DAMAGE RESPONSES WITH IMMUNE DEVELOPMENT AND FUNCTIONK08AI102946 · NIAID · WASHINGTON UNIVERSITY · PI BEDNARSKI, JEFFREY J · 2012 to 2016
$634k
Four Laser, 18 Color Cell Sorter in the SSFFS10RR025518 · NCRR · STANFORD UNIVERSITY · PI HERZENBERG, LEONARD A · 2009 to 2009
$500k
Role of c-Myc up-regulation in Toxoplasma infectionR21AI112962 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 2015 to 2016
$435k
The role of Toxoplasma gondii amino acid hydroxylase 2 in chronic infectionF31AI120649 · NIAID · STANFORD UNIVERSITY · PI MARINO, NICOLE D. · 2015 to 2016
$70k
A NEW ES CELL DELETION RESOURCE AND WILLIAMS SYNDROMEF32HG000205 · NHGRI · JACKSON LABORATORY · PI GOODWIN, NEAL C · 1999 to 1999
–
NCRR NIH HHS S10 RR025518NCRR NIH HHS S10RR025518-01NHGRI NIH HHS F32 HG000205NHGRI NIH HHS P01-35HG000205NHGRI NIH HHS P01 HG000205NIAID NIH HHS F31 AI120649NIAID NIH HHS K08 AI102946NIAID NIH HHS K08AI102946-01NIAID NIH HHS R01 AI073756NIAID NIH HHS R01 AI074953NIAID NIH HHS R01 AI112962NIAID NIH HHS R01 AI73756NIAID NIH HHS R21 AI112962NIAID NIH HHS T32 AI007290NIAID NIH HHS T32 AI007328NINDS NIH HHS NS069375NINDS NIH HHS P30 NS069375
6 · The paper itself

Abstract

unlabelledThe intracellular protozoan Toxoplasma gondii dramatically reprograms the transcriptome of host cells it infects, including substantially up-regulating the host oncogene c-myc. By applying a flow cytometry-based selection to infected mouse cells expressing green fluorescent protein fused to c-Myc (c-Myc-GFP), we isolated mutant tachyzoites defective in this host c-Myc up-regulation. Whole-genome sequencing of three such mutants led to the identification of MYR1 (Myc regulation 1; TGGT1_254470) as essential for c-Myc induction. MYR1 is a secreted protein that requires TgASP5 to be cleaved into two stable portions, both of which are ultimately found within the parasitophorous vacuole and at the parasitophorous vacuole membrane. Deletion of MYR1 revealed that in addition to its requirement for c-Myc up-regulation, the MYR1 protein is needed for the ability of Toxoplasma tachyzoites to modulate several other important host pathways, including those mediated by the dense granule effectors GRA16 and GRA24. This result, combined with its location at the parasitophorous vacuole membrane, suggested that MYR1 might be a component of the machinery that translocates Toxoplasma effectors from the parasitophorous vacuole into the host cytosol. Support for this possibility was obtained by showing that transit of GRA24 to the host nucleus is indeed MYR1-dependent. As predicted by this pleiotropic phenotype, parasites deficient in MYR1 were found to be severely attenuated in a mouse model of infection. We conclude, therefore, that MYR1 is a novel protein that plays a critical role in how Toxoplasma delivers effector proteins to the infected host cell and that this is crucial to virulence. IMPORTANCE: Toxoplasma gondii is an important human pathogen and a model for the study of intracellular parasitism. Infection of the host cell with Toxoplasma tachyzoites involves the introduction of protein effectors, including many that are initially secreted into the parasitophorous vacuole but must ultimately translocate to the host cell cytosol to function. The work reported here identified a novel protein that is required for this translocation. These results give new insight into a very unusual cell biology process as well as providing a potential handle on a pathway that is necessary for virulence and, therefore, a new potential target for chemotherapy.

Indexed as

Host-Pathogen InteractionsAnimalsGene DeletionMacrophagesMiceProtozoan ProteinsToxoplasmaToxoplasmosis, AnimalVirulence FactorsProtozoan ProteinsVirulence Factors

Identifiers

PMID26838724
PMCPMC4742717
OpenAlexW2271466588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.